By expenditures
| Name | Title | Type |
|---|---|---|
| Irene Math | Cfo | Auditee |
| Magdalena Lopez | Partner | Auditee |
| Derek Flanagan | Partner | Auditee |
| Karen Rosenthal | CONTROLLER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 394587 | 2025 | 2026-03-26 | GALLEROS ROBINSON CPA LLP | $6.32M |
| 349416 | 2024 | 2025-03-27 | Galleros Robinson CPA LLP | $6.13M |
| 302098 | 2023 | 2024-04-01 | Galleros Robinson CPA LLP | $4.81M |
| 23650 | 2022 | 2023-03-30 | Galleros Robinson CPA LLP | $3.49M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 394587 | 2025 | 2026-03-26 | 1186846 | 2025-003 | Material Weakness | Yes | AB |
| 394587 | 2025 | 2026-03-26 | 1186845 | 2025-002 | Material Weakness | Yes | L |
| 394587 | 2025 | 2026-03-26 | 1186844 | 2025-003 | Material Weakness | Yes | AB |
| 394587 | 2025 | 2026-03-26 | 1186843 | 2025-002 | Material Weakness | Yes | L |
| 394587 | 2025 | 2026-03-26 | 1186842 | 2025-003 | Material Weakness | Yes | AB |
| 394587 | 2025 | 2026-03-26 | 1186841 | 2025-002 | Material Weakness | Yes | L |
| 394587 | 2025 | 2026-03-26 | 1186840 | 2025-003 | Material Weakness | Yes | AB |
| 394587 | 2025 | 2026-03-26 | 1186839 | 2025-002 | Material Weakness | Yes | L |
| 394587 | 2025 | 2026-03-26 | 1186838 | 2025-003 | Material Weakness | Yes | AB |
| 394587 | 2025 | 2026-03-26 | 1186837 | 2025-002 | Material Weakness | Yes | L |
| 349416 | 2024 | 2025-03-27 | 1115126 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 1115125 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 1115124 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 1115123 | 2024-003 | Significant Deficiency | - | B |
| 349416 | 2024 | 2025-03-27 | 1115122 | 2024-004 | Significant Deficiency | - | N |
| 349416 | 2024 | 2025-03-27 | 1115121 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 1115120 | 2024-001 | Significant Deficiency | - | B |
| 349416 | 2024 | 2025-03-27 | 538684 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 538683 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 538682 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 538681 | 2024-003 | Significant Deficiency | - | B |
| 349416 | 2024 | 2025-03-27 | 538680 | 2024-004 | Significant Deficiency | - | N |
| 349416 | 2024 | 2025-03-27 | 538679 | 2024-002 | Significant Deficiency | Yes | B |
| 349416 | 2024 | 2025-03-27 | 538678 | 2024-001 | Significant Deficiency | - | B |
| 302098 | 2023 | 2024-04-01 | 968099 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 968098 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 968097 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 968096 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 968095 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 968094 | 2023-001 | Significant Deficiency | Yes | AB |
| 302098 | 2023 | 2024-04-01 | 391657 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 391656 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 391655 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 391654 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 391653 | 2023-001 | Significant Deficiency | - | AB |
| 302098 | 2023 | 2024-04-01 | 391652 | 2023-001 | Significant Deficiency | Yes | AB |
| 23650 | 2022 | 2023-03-30 | 601576 | 2022-002 | Significant Deficiency | Yes | P |
| 23650 | 2022 | 2023-03-30 | 601575 | 2022-001 | Significant Deficiency | Yes | A |
| 23650 | 2022 | 2023-03-30 | 25134 | 2022-002 | Significant Deficiency | Yes | P |
| 23650 | 2022 | 2023-03-30 | 25133 | 2022-001 | Significant Deficiency | Yes | A |